Quantcast

Anesthetic considerations in the patient with valvular heart disease undergoing noncardiac surgery.

Research paper by Alexander Jc AJ Mittnacht, Michael M Fanshawe, Steven S Konstadt

Indexed on: 10 Apr '08Published on: 10 Apr '08Published in: Seminars in cardiothoracic and vascular anesthesia



Abstract

Valvular heart disease can be an important finding in patients presenting for noncardiac surgery. Valvular heart disease and resulting comorbidity, such as heart failure or atrial fibrillation, significantly increase the risk for perioperative adverse events. Appropriate preoperative assessment, adequate perioperative monitoring, and early intervention, should hemodynamic disturbances occur, may help prevent adverse events and improve patient outcome. This review article aims to guide the practitioner in the various aspects of anesthetic management in the perioperative care of patients with valvular heart disease. The pharmacological approach to optimization of patient outcome with drugs, such as betablockers and lipid-lowering medications (statins), is an evolving field, and recent developments are discussed in this article.